Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
3.550
+0.040 (1.14%)
Oct 9, 2026, 3:04 PM CST
SHE:002198 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 350.56 | 383.75 | 376.17 | 533.23 | 659.2 | 574.71 |
Revenue Growth | -11.23% | 2.02% | -29.45% | -19.11% | 14.70% | 5.50% |
Gross Profit Gross Profit Growth | 189.89 | 226.12 | 224.04 | 346.9 | 429.98 | 431.45 |
Operating Income Operating Income Growth | 10.84 | 40.5 | 20.75 | 35.56 | 50.22 | 29.29 |
Net Income Net Income Growth | -2.58 | 30.48 | 20.61 | 34.32 | 43.93 | 1.48 |
Earnings Per Share EPS Growth | -0.01 | 0.06 | 0.04 | 0.07 | 0.09 | 0.00 |
EPS Growth | - | 48.03% | -39.94% | -21.94% | 2886.21% | -92.58% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 348.56 | 382.92 | 375.41 | 533.23 | 659.03 | 574.6 |
Unallocated Other Unallocated Other Growth | - | 0.84 | 0.76 | - | 0.17 | 0.11 |
Total Total Growth | 350.56 | 383.75 | 376.17 | 533.23 | 659.2 | 574.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 128.45 | 177.11 | 336.14 | 335.74 | 236 | 242.89 |
Total Debt Total Debt Growth | 20 | - | - | - | - | 31.11 |
Net Cash (Debt) Net Cash Growth | 108.45 | 177.11 | 336.14 | 335.74 | 236 | 211.78 |
Net Cash Growth | -47.37% | -47.31% | 0.12% | 42.26% | 11.44% | 70.91% |
Net Cash Per Share Net Cash Per Share Growth | 0.21 | 0.35 | 0.66 | 0.66 | 0.47 | 0.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -20.41 | 9 | 60.85 | 98.45 | 27.15 | 51.8 |
Capital Expenditures CapEx Growth | -103.11 | -109.92 | -38.7 | -5.06 | -2.74 | -2.34 |
Free Cash Flow Free Cash Flow Growth | -123.52 | -100.92 | 22.14 | 93.39 | 24.41 | 49.46 |
Free Cash Flow Growth | - | - | -76.29% | 282.53% | -50.63% | -41.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 54.17% | 58.92% | 59.56% | 65.05% | 65.23% | 75.07% |
Operating Margin | 3.09% | 10.55% | 5.51% | 6.67% | 7.62% | 5.10% |
Pretax Margin | 0.67% | 9.89% | 6.67% | 7.38% | 7.75% | 1.01% |
Profit Margin | -0.74% | 7.94% | 5.48% | 6.44% | 6.67% | 0.26% |
FCF Margin | -35.23% | -26.30% | 5.89% | 17.51% | 3.70% | 8.61% |
| Fiscal Year | FY 2023 |
|---|---|
| Period Ending | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.050 |
Dividend Per Share Growth | - |
Dividend Yield | 0.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 117.06 | 180.24 | 107.65 | 75.32 | 2707.14 |
Forward PE | - | 21.70 | 21.70 | 21.70 | 21.70 | 21.70 |
P/FCF Ratio | - | - | 167.76 | 39.56 | 135.53 | 80.86 |
PS Ratio | 5.03 | 9.30 | 9.88 | 6.93 | 5.02 | 6.96 |